Login / Signup

Clinical trial protocol for PanDox: a phase I study of targeted chemotherapy delivery to non-resectable primary pancreatic tumours using thermosensitive liposomal doxorubicin (ThermoDox®) and focused ultrasound.

Laura SpiersMichael GrayPaul LyonShivan SivakumarNoor BekkaliShaun ScottLinda CollinsRobert CarlisleFeng WuMark MiddletonConstantin Coussios
Published in: BMC cancer (2023)
April 2022. EudraCT number: 2019-003950-10 (Registered 2019) Iras Project ID: 272253 (Registered 2019) Ethics Number: 20/EE/0284.
Keyphrases
  • clinical trial
  • locally advanced
  • cancer therapy
  • randomized controlled trial
  • public health
  • drug delivery
  • quality improvement
  • study protocol
  • phase ii
  • radiation therapy
  • machine learning
  • liver metastases
  • global health